Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06240143 |
| Title | Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (MARIANE) |
| Acronym | MARIANE |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | The Netherlands Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NLD |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Amsterdam University Medical Center | NOT_YET_RECRUITING | Amsterdam | Netherlands | Details | ||
| Antoni van Leeuwenhoek Hospital | RECRUITING | Amsterdam | Netherlands | Details | ||
| University Medical Center Groningen | RECRUITING | Groningen | Netherlands | Details | ||
| Leiden University Medical Center | NOT_YET_RECRUITING | Leiden | Netherlands | Details | ||
| Erasmus University Medical Center | NOT_YET_RECRUITING | Rotterdam | Netherlands | Details | ||
| University Medical Center Utrecht | NOT_YET_RECRUITING | Utrecht | Netherlands | Details |